Canadian Online Pharmacy

CDER New August 1, 2014

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

July 31, 2014


New and Generic Drug Approvals

July 30, 2014

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Absorica isotretinoin Capsule;Oral Ranbaxy Labeling Revision
Amoxil amoxicillin For Suspension;Oral Dr Reddys Labs Inc Manufacturing Change or Addition
Belviq lorcaserin hydrochloride Tablet;Oral Eisai Inc Manufacturing Change or Addition
Canasa mesalamine Suppository;Rectal Forest Labs Inc Manufacturing Change or Addition
Diclegis doxylamine succinate; pyridoxine hydrochloride Tablet, Delayed Release;Oral Duchesnay Manufacturing Change or Addition
Excedrin (Migraine) acetaminophen; aspirin; caffeine Tablet;Oral Novartis Manufacturing Change or Addition
Humatrope somatropin recombinant Injectable;Injection Lilly Labeling Revision
Iclusig ponatinib hydrochloride Tablet;Oral Ariad Manufacturing Change or Addition
Jentadueto linagliptin; metformin hydrochloride Tablet;Oral Boehringer Ingelheim Efficacy Supplement with Clinical Data to Support
Quelicin succinylcholine chloride Injectable;Injection Hospira Manufacturing Change or Addition
Quelicin Preservative Free succinylcholine chloride Injectable;Injection Hospira Manufacturing Change or Addition

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery